Diabetic Nephropathy Archives - Page 5 of 14

ERA Congress, Secondary Hyperparathyroidism

Study: Etelcalcetide Can Be Used Safely in Diabetic Nephropathy

By

Natasha Persaud

June 10, 2021

Etelcalcetide use in patients with diabetic nephropathy might protect against development of adynamic bone disease, according to investigators.

Diabetic Nephropathy

Finerenone Improves Cardiovascular Outcomes in Patients With Diabetic Kidney Disease

By

Brian Park, PharmD

May 13, 2021

The study evaluated finerenone in addition to standard of care in patients with chronic kidney disease and type 2 diabetes.

black senior couple hospital sad patient african a

Diabetic Nephropathy

Afro-Caribbean Ethnicity Linked to Non-Linear eGFR Decline in DKD

By

Natasha Persaud

May 11, 2021

Non-linear renal function decline frequently occurs in patients with type 2 diabetes and is associated with faster progression to end-stage kidney disease.

Diabetic Nephropathy

Hypertension, Albuminuria Common in Pediatric Type 2 Diabetes

By

Natasha Persaud

May 6, 2021

The prevalence of hypertension and albuminuria in pediatric patients with type 2 diabetes varies by race.

Chronic Kidney Disease (CKD)

Dapagliflozin Reduces Risk for Kidney Events in IgA Nephropathy

By

Natasha Persaud

May 5, 2021

In patients with IgA nephropathy, dapagliflozin significantly reduced the risk of CKD progression when added to ACEi/ARB therapy.

Diabetic Nephropathy

Decreased UACR Linked to Reduced Risk for Cardiovascular, Renal Events in T2D

By

Rose Reeb

March 5, 2021

Urinary albumin-to-creatinine ratio values are often used to guide treatment decisions as albuminuria is known to be a strong predictor of cardiovascular and renal events.

Diabetic Nephropathy

Albuminuria Reduction Greater With SGLT2 Inhibitor, ERA Combo

By

Natasha Persaud

March 17, 2021

A move toward combination therapies is inevitable in the new paradigm for diabetic kidney disease management, according to the authors of an editorial.